Physician profile
Mitchell Goettman
NPI 1437573045
$3,040.61
in general payments reported to CMS, 2019-2025
10 companies · $2,571 in 2025
The $2,571 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $93.80 · 2022: $179 · 2023: $48.53 · 2024: $20.04 · 2025: $2,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $899 · Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $899.45 |
| Food and Beverage | $240.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,650.64 | 2022-2025 | |
| Davol INC. | $120.02 | 2020-2022 | |
| Tela Bio, INC. | $73.78 | 2020 | |
| Ethicon US, LLC | $63.56 | 2019 | |
| Csl Behring | $34.12 | 2019 | |
| Medtronic, INC. | $33.26 | 2023 | Ligasure |
| Becton, Dickinson and Company | $20.04 | 2024 | Phasix Mesh |
| Kci USA, INC. | $15.27 | 2023 | Prevena |
| Bard Peripheral Vascular, INC. | $15.10 | 2019 | |
| Acell, INC. | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Goettman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.